Baylor College of Medicine researchers participated in a study on CAR T-cell therapy, co-authored by Andras Heczey.
1 report, 1 independent
Updated Sep 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Baylor College of Medicine researchers participated in a study on CAR T-cell therapy, co-authored by Andras Heczey.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Baylor College of Medicine
private medical school in Houston, Texas, United States
Nothing else this week.
- FDA
Related events
- FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.
- Experimental therapies require approval from the FDA.
- A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.
- Solid Biosciences received FDA approval for a gene therapy trial on July 9, 2025.